News

Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...
Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...
AD is a growing market with an impressive pipeline of new products from current and future players in the field.
A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...
Atopic dermatitis, asthma, and allergic rhinitis are among the allergic diseases tied to a significantly increased risk for ...
Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.
People allergic to garlic experience immune-related symptoms to allicin and similar compounds. Find guidance on navigating ...
Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.
Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.
Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic ...